Imatinib Mesylate 00832-0532
Product NDC
00832-0532- Manufacturer
- Upsher-Smith Laboratories, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 17, 2024
- Application
- ANDA212135
Need to source Imatinib Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Imatinib Mesylate | 100 mg/1 |
Drug Class
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]Cytochrome P450 2D6 Inhibitors [MoA]Cytochrome P450 3A4 Inhibitors [MoA]
Packaging Options(1)
90 TABLET in 1 BOTTLE (0832-0532-09)